Physician profile
Jonathan Redditt
NPI 1467835777
$828.62
in general payments reported to CMS, 2019-2025
8 companies · $441 in 2025
The $441 reported for 2025 was more than what 76% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.68 · 2022: $203 · 2024: $154 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.73 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $347.79 | 2022-2025 | Na |
| Medical Device Business Services, INC. | $137.01 | 2025 | Stratafix |
| Straumann USA LLC | $107.35 | 2025 | |
| Kls-Martin L.P. | $77.94 | 2022 | |
| Nobel Biocare USA | $64.52 | 2022 | |
| Ethicon US, LLC | $49.54 | 2025 | Vistaseal |
| Acera Surgical, INC. | $30.68 | 2020 | |
| Biohorizons Implant Systems INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Redditt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.